ST Bailing
SZSE · 002424
Market Cap$6.5B
Revenue$2.9B
Employees5715
Listed OnSZSE
Ticker002424
CEO / ExecMr. Wei Jiang
HeadquartersAnshun
MarketMainland China
Websitewww.gzbl.com
Overview
Guizhou Bailing Group Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells medicines in China. It operates through four segments: Industrial, Commerce, Medical institutions, and Others The company offers medicines in various forms, including tablets, capsules, granules, syrups, powders, pills, dews, pastes, sprays, and oral liquids, as well as wines and honey. Its products are used for cardiovascular, cough, cold, gynecological, and pediatric areas.
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.